Elanco Animal Health
ELAN | NYSE
$22.43
+$0.01 (+0.04%)
At close: Sep 21, 2026, 3:59 PM ET
$22.55
+$0.12 (+0.53%)
Pre-market:
Sep 22, 2026, 8:17 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 4.72B | 4.44B | 4.42B | 4.41B | 4.76B | 3.27B |
Cost of Revenue | 2.67B | 2.53B | 2.48B | 2.44B | 2.69B | 2.03B |
Gross Profit | 2.05B | 1.91B | 1.94B | 1.97B | 2.08B | 1.25B |
Operating Income | 252M | 251M | 326M | 384M | 304M | -76.8M |
Interest Income | 45M | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -224M | 488M | -1.2B | -72M | -571M | -672M |
Net Income | -232M | 338M | -1.23B | -78M | -483M | -560.1M |
Selling & General & Admin | 1.43B | 1.31B | 1.29B | 1.27B | 1.4B | 996.6M |
Research & Development | 368M | 344M | 327M | 321M | 369M | 327M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 1.8B | 1.66B | 1.61B | 1.59B | 1.77B | 1.32B |
Interest Expense | 220M | 339M | 277M | 256M | 264M | 156M |
Selling & Marketing Expenses | n/a | 236M | n/a | n/a | n/a | n/a |
Cost & Expenses | 4.46B | 4.19B | 4.09B | 4.03B | 4.46B | 3.35B |
Income Tax Expense | 8M | 150M | 36M | 6M | -88M | -111.9M |
Shares Outstanding (Basic) | 496.4M | 494M | 492.3M | 488.3M | 487.2M | 441.4M |
Shares Outstanding (Diluted) | 496.4M | 497.3M | 492.3M | 488.3M | 487.2M | 441.4M |
EPS (Basic) | -0.47 | 0.68 | -2.50 | -0.15 | -0.97 | -1.27 |
EPS (Diluted) | -0.47 | 0.68 | -2.50 | -0.15 | -0.97 | -1.27 |
EBITDA | 676M | 1.49B | -224M | 866M | 409M | 900K |
EBIT | -4M | 827M | -918M | 184M | -307M | -516M |
Depreciation & Amortization | 680M | 662M | 694M | 682M | 716M | 516.9M |
Add to Watchlist
Select watchlists to add or remove ELAN